What the studies show
No significant difference from placebo.
Animal studies, cell studies, or anecdotes only. This is where almost every viral peptide sits. Promising and proven are different words for a reason.
- 1Pooled analysis of published and unpublished AOD-9604 human trials (900+ participants): no significant difference in fat mass or body weight versus placebo.Evidence review, 2025Secondary source summarising the trial programme and its termination for lack of efficacy.
In context
AOD-9604 is a fragment of human growth hormone developed specifically as an obesity drug. Unlike most peptides sold online, it was tested properly: pooled data across trials covering more than 900 participants found no statistically significant difference in fat mass or body weight against placebo. Development was terminated for lack of efficacy. It is still marketed for fat loss.
AOD-9604 is not approved. Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is AOD-9604 proven to help with body weight?
What studies are behind the grade?
Is AOD-9604 approved for this?
Other outcomes for AOD-9604
- DFat mass reductionPooled trials, 900+ participants
- DOsteoarthritis / cartilageNone conclusive
- CSafety in humansadverseTrial programme
Reviewed 2 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →